// company-profile

Immunovant, Inc.

IMVT
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings189Insiders19
// api This Immunovant, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 8 insiders purchased shares versus 3 sales. Buying was led by Fromkin Andrew J..

// 90-day insight

Over the last 90 days, Immunovant, Inc. insiders bought $1.6M (30 transactions) and sold $9.1M (13 transactions).

  • Most active insider: Fromkin Andrew J. with 12 transactions totaling $9.1M.
  • Largest single sale: $7.1M by Fromkin Andrew J. on May 28, 2026.
  • 19% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Immunovant, Inc. as of 2026-03-31

— stable
Total reported AUM
$2.60B
QoQ change
+4.5%
Reporting period
2026-03-31
#1
Deep Track Capital, LP
CIK 1856083
$286.3M
11.5M shares
#2
FMR LLC
CIK 315066
$239.2M
9.6M shares
#3
FMR LLC
CIK 315066
$181.0M
7.3M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 18, 2026Van Tuyl ChristopherIMVT
Sale
2,634$35.39$93K
Jun 15, 2026Pande AtulIMVT
Sale10b5
1,500$34.02$51K
Jun 15, 2026Pande AtulIMVT
Option Exercise10b5
1,500$8.43$13K
Jun 15, 2026Pande AtulIMVT
Option Exercise10b5
1,500$0.00$0K
May 28, 2026Fromkin Andrew J.IMVT
Sale
11,483$32.64$375K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.